YTHDF1 and cancer: Screening for potential post-transcriptional regulations revealed that the cancer variant falls within the target binding regions of six RBPs, including the m6A reader YTHDF1, which is known to bind m6A-containing RNAs and promote cancer stem cell properties of GBM cells [106].